Evidence map›Paper›PMID 41348876›Full record

ArticleScience advances2025

Scalable metal-organic framework membranes through nonclassical crystallization for molecular separation.

Dongchen Shi, Fen Huang, Kai Xue, Xiansong Shi, Nengxiu Zhu, Kexin Yu, Zhaoqiang Zhang, Yidan Duan, Ting Chen, Hongye Yuan and 4 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dongchen ShiDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0001-6669-4154
Fen HuangDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0009-0001-7864-8531
Kai XueCenter of High Field NMR Spectroscopy and Imaging, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.ORCID 0000-0001-7824-5516
Xiansong ShiDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-4258-7941
Nengxiu ZhuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.
Kexin YuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0001-6261-7485
Zhaoqiang ZhangDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-9172-2871
Yidan DuanDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-9305-693X
Ting ChenDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.
Hongye YuanDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-2997-7793
Hao YangDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-2798-1246
Wei ZhaoDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0003-0265-2590
Joseph ImbrognoChemical Research and Development, Pfizer Worldwide Research and Development, Groton, CT 06340, USA.ORCID 0000-0002-4670-9432
Dan ZhaoDepartment of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117585, Singapore.ORCID 0000-0002-4427-2150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structurally ordered metal-organic framework (MOF) membranes hold great promise for selective molecular separations in chemical and pharmaceutical industries due to their precise pore size control and strong stability in organic solvents. However, the high surface energy of MOF nanodispersions complicates their assembly, leading to nonselective grain boundaries and poor processability, which hinder practical application. Here, we present a metastable phase crystallization (MPC) strategy that leverages nonclassical crystallization pathways to fabricate MOF membranes with high precision and structural uniformity. This approach combines sol-gel coating with vapor-phase reactions and ligand insertion, enabling the preparation of membranes with finely tunable pore sizes. Al-MOF membranes prepared by MPC exhibit excellent solvent permeance and solute retention, together with enhanced stability under elevated pressures and long-term operation. By tailoring pore sizes through ligand incorporation, molecular separation performance is further improved. A 10-tube tubular MOF membrane module with an effective area of 230 square centimeters highlights the potential scalability of this approach for industrial separations.

Identifiers

PMID41348876
PMCPMC12680047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.